Evaluating the influence of Human Umbilical Cord Mesenchymal Stem Cells-derived exosomes loaded with miR-3182 on metastatic performance of Triple Negative Breast Cancer cells

Life Sciences ◽  
2021 ◽  
Vol 286 ◽  
pp. 120015
Author(s):  
Yalda Khazaei-Poul ◽  
Samaneh Shojaei ◽  
Ameneh Koochaki ◽  
Hossein Ghanbarian ◽  
Samira Mohammadi-Yeganeh
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Cancer Cells ◽  
Umbilical Cord ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Human Umbilical Cord

scholarly journals Embelin downregulated cFLIP in breast cancer cell lines facilitate anti-tumor effect of IL-1β-stimulated human umbilical cord mesenchymal stem cells

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Ya-Han Liang ◽  
Jiann-Ming Wu ◽  
Jui-Wen Teng ◽  
Eric Hung ◽  
Hwai-Shi Wang
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Cancer Therapy ◽  
Cancer Cells ◽  
Umbilical Cord ◽  
Breast Cancer Cells ◽  
Breast Cancer Cell Lines ◽  
Human Umbilical Cord ◽  
Trail Resistance

AbstractBreast cancer is the leading cause of cancer-related death for women. In breast cancer treatment, targeted therapy would be more effective and less harmful than radiotherapy or systemic chemotherapy. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to induce apoptosis in cancer cells but not in normal cells. Mesenchymal stem cells have shown great therapeutic potential in cancer therapy owing to their ability of homing to tumor sites and secreting many kinds of anti-tumor proteins including TRAIL. In this study, we found that IL-1β-stimulated human umbilical cord-derived mesenchymal stem cells (hUCMSCs) enhance the expression of membrane-bound and soluble TRAIL. Cellular FADD-like IL-1β-converting enzyme inhibitory protein (cFLIP) is an important regulator in TRAIL-mediated apoptosis and relates to TRAIL resistance in cancer cells. Previous studies have shown that embelin, which is extracted from Embelia ribes, can increase the TRAIL sensitivity of cancer cells by reducing cFLIP expression. Here we have demonstrated that cFLIPL is correlated with TRAIL-resistance and that embelin effectively downregulates cFLIPL in breast cancer cells. Moreover, co-culture of IL-1β-stimulated hUCMSCs with embelin-treated breast cancer cells could effectively induce apoptosis in breast cancer cells. The combined effects of embelin and IL-1β-stimulated hUCMSCs may provide a new therapeutic strategy for breast cancer therapy.

scholarly journals Human umbilical cord matrix-derived stem cells expressing interferon-β gene inhibit breast cancer cells via apoptosis

Oncotarget ◽  
2016 ◽  
Vol 7 (23) ◽  
pp. 34172-34179 ◽  
Author(s):  
Ching-Ju Shen ◽  
Te-Fu Chan ◽  
Chien-Chung Chen ◽  
Yi-Chiang Hsu ◽  
Cheng-Yu Long ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Cells ◽  
Umbilical Cord ◽  
Breast Cancer Cells ◽  
Human Umbilical Cord ◽  
Interferon Β ◽  
Umbilical Cord Matrix

Regulation of stem cells-related signaling pathways in response to doxorubicin treatment in Hs578T triple-negative breast cancer cells

2015 ◽  
Vol 409 (1-2) ◽  
pp. 163-176 ◽  
Author(s):  
Oana Tudoran ◽  
Olga Soritau ◽  
Loredana Balacescu ◽  
Simona Visan ◽  
Otilia Barbos ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Cells ◽  
Signaling Pathways ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Doxorubicin Treatment

scholarly journals The Radio-Sensitivity Effects of Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cell’s Conditional Medium on MDA-MB-231 Cells

2020 ◽  
Vol 11 (3) ◽  
Author(s):  
Hamed Shoghi ◽  
Niloofar Neisi ◽  
Ghasem Saki ◽  
Mohamad Javad Tahmasebi Biragani ◽  
Amir Danyaei
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Cells ◽  
Conditioned Medium ◽  
Umbilical Cord ◽  
Breast Cancer Cells ◽  
Control Group ◽  
Human Umbilical Cord ◽  
Wharton's Jelly ◽  
Different Doses

Background: While radiotherapy is the important modality in the treatment of breast cancer cells, radioresistance of some tumor cell lines such as MDA-MB-231 is still a limitation that must be considered. Objectives: The present study was done to examine the effect of the conditioned medium of the human umbilical cord Wharton's jelly stem cells (hWJSCs + CM) on the radiosensitivity of MDA-MB-231 cells in combination with megavoltage-radiations. Methods: Groups are Control, CM, GY, and GY + CM. In irradiation groups, breast cancer cells were exposured with 4, 6, and 8 Gy radiation. Each group includes different doses of the conditioned medium of hWJSCs (25%, 50%, and 75%). Results: The MTT assay showed that the proliferative activity of Gy + CM groups at all doses of condition medium decreased significantly compared with the control, rather than Gy groups. Trypan blue viability test showed that the survival rate of MDA-MB-231 cells significantly reduced in the CM and 8 Gy + CM groups compared with the control group, rather than Gy groups. MDA-MB-231 cells lost their normal spindle shape and became thinner and longer after 48h of treatment and the number of cells sharply reduced in Gy + CM groups compared with the control group, rather than Gy groups. These changes were accompanied by inducing significant up-regulation of Interleukin-6 (IL-6) in the 4 Gy + CM and 8 Gy + CM groups compared with the control group, rather than Gy groups and as a consequence, a decrease in the amount of transmembrane tumor necrosis factor-α (tmTNF-α) as a pro-inflammatory cytokine in the Gy + CM groups compared with the control group, rather than Gy groups. Also, we indicated that the radiosensitivity of breast cancer cells was probably enhanced by an increase in different doses of the conditioned medium of stem cells. Conclusions: Treatment of the MDA-MB-231 cells with hWJSCs + CM plus radiotherapy inhibited the growth and proliferation of cancer cells and this method is a novel strategy for breast cancer therapy by overcoming radioresistance.

Sign in / Sign up

Export Citation Format

Share Document